Income Statement
DENALI THERAPEUTICS INC.
DNLI
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY |
|---|---|---|---|---|---|---|---|---|
|
Revenue
|
0.00 | 0.00 | 330.53 | 108.46 | 48.66 | 335.66 | 26.68 | 129.16 |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - |
|
Gross Profit
|
- | - | 330.53 | 108.46 | 48.66 | 335.66 | 26.68 | 129.16 |
|
Operating Expenses
|
555.34 | 501.88 | 527.23 | 449.21 | 344.41 | 272.94 | 239.86 | 175.53 |
|
Research & Development
|
418.78 | 396.44 | 423.88 | 358.73 | 265.35 | 212.62 | 193.38 | 143.18 |
|
Selling, General & Administrative
|
136.56 | 105.44 | 103.35 | 90.48 | 79.06 | 60.33 | 46.48 | 32.35 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - |
|
Operating Income
|
-555.34 | -501.88 | -196.70 | -340.74 | -295.75 | 62.72 | -213.18 | -46.37 |
|
Non-Operating Income
|
- | - | 51.51 | 14.77 | 4.60 | 9.24 | 15.22 | 10.13 |
|
Interest Income
|
- | - | - | - | - | - | - | - |
|
Interest Expense
|
- | - | - | - | - | - | - | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | - | - | - |
|
Income Before Tax
|
- | - | - | - | - | - | - | - |
|
Income Tax Expense
|
0.10 | 0.07 | 0.03 | 0.02 | -0.58 | -0.82 | -0.40 | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - |
|
Net Income
|
-512.54 | -422.77 | -145.22 | -325.99 | -290.58 | 71.14 | -197.61 | -36.24 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY |
|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - |
|
EBITDA
|
-544.14 | -494.08 | -179.97 | -330.34 | -287.15 | 71.25 | -205.18 | -38.96 |
|
Earnings Per Share (Basic)
|
-2.97 | -2.57 | -1.06 | -2.60 | -2.39 | 0.65 | - | - |
|
Diluted EPS
|
-2.97 | -2.57 | -1.06 | -2.60 | -2.39 | 0.63 | - | - |
|
Weighted Average Shares
|
172.65 | 164.47 | 137.37 | 125.53 | 121.52 | 108.97 | - | - |
|
Diluted Weighted Avg Shares
|
172.65 | 164.47 | 137.37 | 125.53 | 121.52 | 112.70 | - | - |
|
Comprehensive Income
|
-513.88 | -421.40 | -137.70 | -330.38 | -292.84 | 70.54 | -196.62 | -36.52 |